The results showed that in breast cancer, GPS1 expression was positively correlated with LAG3, PVRL2, and LGALS9 (Fig. 12B), and negatively correlated with CD274 and HAVCR2, but not with CTLA4 and PDCD1. Here, GPS1 is linked to breast cancer.